logo

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Annexon, Inc.


USPTO Granted Patents = 14


Forward Citations = 31

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Arnon Rosenthal (9 out of 122 patents)

silverMedal Michael W Leviten (9 out of 11 patents)

bronzeMedal Sethu Sankaranarayanan (4 out of 4 patents)

4.  Ted A Yednock (4 out of 11 patents)

5.  Federico Sorana (3 out of 8 patents)

6.  Dean R Artis (3 out of 40 patents)

7.  Bruno Di Guglielmo (3 out of 3 patents)

8.  Claudia Beato (3 out of 3 patents)

9.  Luca B Mileo (3 out of 3 patents)

10.  Colin P Leslie (3 out of 3 patents)

11.  Chiara Padroni (3 out of 3 patents)

12.  Federica Faroldi (1 out of 1 patent)

13.  Alan S Verkman (38 patents)

14.  Karen Krukowski (2 patents)

15.  Susanna Rosi (0 patent)


14 patents:

1. 12735473 - METHOD OF TREATING A BLOOD DISORDER ASSOCIATED WITH C1Q-MEDIATED ACTIVATION OF THE CLASSICAL COMPLEMENT PATHWAY BY ADMINISTERING AN ANTI-C1Q ANTIBODY (2026-09-15),
2. 12534522 - ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES AND USES THEREOF (2026-01-27),
3. 12522619 - Inhibitors of complement factors and uses thereof (2026-01-13),
4. 12509474 - Inhibitors of complement factors and uses thereof (2025-12-30),
5. 12486322 - ANTI-COMPLEMENT FACTOR C1Q ANTIBODIES WITH SINGLE BINDING ARMS AND USES THEREOF (2025-12-02),
6. 11999779 - Anti-complement factor C1q Fab fragments and uses thereof (2024-06-04),
7. 11814404 - Inhibitors of complement factors and uses thereof (2023-11-14),
8. 11649279 - Anti-complement factor C1Q antibodies and uses thereof (2023-05-16),
9. 10927167 - Anti-complement factor C1Q antibodies and uses thereof (2021-02-23),
10. 10723788 - Anti-complement factor C1q Fab fragments and uses thereof (2020-07-28),
11. 10590190 - Anti-complement factor C1q antibodies and uses thereof (2020-03-17),
12. 10316081 - Humanized anti-complement factor C1Q antibodies (2019-06-11),
13. 10227398 - Anti-complement factor C1q antibodies and uses thereof (2019-03-12),
14. 9708394 - Anti-complement factor C1q antibodies and uses thereof (2017-07-18),
Company Overview
Annexon, Inc. is a biotechnology company based in South San Francisco, California, focused on developing innovative therapies for neurodegenerative diseases and autoimmune disorders. The company specializes in harnessing the body's immune system to target and eliminate harmful proteins that contribute to disease progression. With a commitment to advancing scientific understanding, Annexon is at the forefront of research aimed at transforming treatment paradigms in areas of significant unmet medical need.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

Annexon, Inc. USPTO Patent Assignee Logo
14 Patents

#82 in South San Francisco, CA

#5,322 in California

#22,333 in US

#42,290 in the World

South San Francisco, CA (US)
South San Francisco, CA, United States of America

Annexon, Inc.

Forward Citations = 31

13 inventors:

goldMedal Arnon Rosenthal (9 out of 122 patents)

silverMedal Michael W Leviten (9 out of 11 patents)

bronzeMedal Sethu Sankaranarayanan (4 out of 4 patents)

4.  Ted A Yednock (4 out of 11 patents)

5.  Federico Sorana (3 out of 8 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Annexon, Inc.. Retrieved from https://idiyas.com/company/annexon

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…